242 related articles for article (PubMed ID: 23653308)
1. Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models.
Wang X; Ma C; Wu J; Zhu J
J Neurosci Res; 2013 Jul; 91(7):871-81. PubMed ID: 23653308
[TBL] [Abstract][Full Text] [Related]
2. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
[TBL] [Abstract][Full Text] [Related]
3. Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis.
Zhang HL; Zheng XY; Zhu J
Cytokine Growth Factor Rev; 2013 Oct; 24(5):443-53. PubMed ID: 23791985
[TBL] [Abstract][Full Text] [Related]
4. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
Jadidi-Niaragh F; Mirshafiey A
Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
[TBL] [Abstract][Full Text] [Related]
5. Are Th17 cells and their cytokines a therapeutic target in Guillain-Barré syndrome?
Wu X; Wang J; Liu K; Zhu J; Zhang HL
Expert Opin Ther Targets; 2016; 20(2):209-22. PubMed ID: 26357850
[TBL] [Abstract][Full Text] [Related]
6. miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3.
Zhu E; Wang X; Zheng B; Wang Q; Hao J; Chen S; Zhao Q; Zhao L; Wu Z; Yin Z
J Immunol; 2014 Jun; 192(12):5599-609. PubMed ID: 24842756
[TBL] [Abstract][Full Text] [Related]
7. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
Maddur MS; Miossec P; Kaveri SV; Bayry J
Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints.
Miyamoto Y; Uga H; Tanaka S; Kadowaki M; Ikeda M; Saegusa J; Morinobu A; Kumagai S; Kurata H
Mol Immunol; 2013 Jun; 54(2):199-207. PubMed ID: 23287598
[TBL] [Abstract][Full Text] [Related]
9. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis.
Zhang J; Cheng Y; Cui W; Li M; Li B; Guo L
J Neuroimmunol; 2014 Jan; 266(1-2):56-63. PubMed ID: 24332164
[TBL] [Abstract][Full Text] [Related]
11. Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation.
Yoshida H; Kimura A; Fukaya T; Sekiya T; Morita R; Shichita T; Inoue H; Yoshimura A
Biochem Biophys Res Commun; 2012 Feb; 418(2):234-40. PubMed ID: 22252297
[TBL] [Abstract][Full Text] [Related]
12. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.
Luchtman DW; Ellwardt E; Larochelle C; Zipp F
Cytokine Growth Factor Rev; 2014 Aug; 25(4):403-13. PubMed ID: 25153998
[TBL] [Abstract][Full Text] [Related]
13. The Interleukin (IL)-23/T helper (Th)17 Axis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Hiltensperger M; Korn T
Cold Spring Harb Perspect Med; 2018 Jan; 8(1):. PubMed ID: 29101111
[TBL] [Abstract][Full Text] [Related]
14. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
15. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
Prochazkova J; Pokorna K; Holan V
Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
[TBL] [Abstract][Full Text] [Related]
16. Targeting the development and effector functions of TH17 cells.
Ghilardi N; Ouyang W
Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells.
Li XL; Dou YC; Liu Y; Shi CW; Cao LL; Zhang XQ; Zhu J; Duan RS
Cell Immunol; 2011; 271(2):455-61. PubMed ID: 21889126
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
[TBL] [Abstract][Full Text] [Related]
19. Loss of Sprouty4 in T cells ameliorates experimental autoimmune encephalomyelitis in mice by negatively regulating IL-1β receptor expression.
Fukaya T; Someya K; Hibino S; Okada M; Yamane H; Taniguchi K; Yoshimura A
Biochem Biophys Res Commun; 2014 May; 447(3):471-8. PubMed ID: 24732356
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of antigen specific Th17 cells differentiation in experimental autoimmune uveitis].
Chen HT; Wang H; Zhao M; Hou B
Zhonghua Yan Ke Za Zhi; 2012 Mar; 48(3):234-40. PubMed ID: 22800421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
